Serine/threonine protein kinase 3D structures: Difference between revisions

← Older edit Newer edit →

Revision as of 07:44, 19 August 2026

3D structures of serine/threonine protein kinase

Updated on 19-August-2026

Chk1; domains - kinase 1-289; KA1 393-492
- 1ia8 – hChk1 kinase domain – human
- 5w12 – hChk1 KA1 domain
- 1zlt – hChk1 kinase domain + hymenaldisine
- 1nvq, 1nvr – hChk1 kinase domain + peptide + saurosporine
- 1nvs, 1zys, 7ako - hChk1 kinase domain + peptide + inhibitor
- 7akm - hChk1 kinase domain + ATP
- 2ayp, 2br1, 2brb, 2brg, 2brh, 2brm, 2brn, 2bro, 2c3j, 2c3k, 2c3l, 2cgu, 2cgv, 2cgw, 2cgx, 2e9n, 2e9o, 2e9p, 2e9u, 2e9v, 2gdo, 2ghg, 2hog, 2hxl, 2hxq, 2hy0, 2qhm, 2qhn, 2r0u, 3f9n, 2wmq, 2wmr, 2wms, 2wmt, 2wmu, 2wmv, 2wmw, 2wmx, 2xey, 2xf0, 2xez, 2x8d, 2x8e, 2x8i, 2ydi, 2ydj, 2ydk, 2yer, 2yex, 2ym3, 2ym4, 2ym5, 2ym6, 2ym7, 2ym8, 2ywp, 3jvr, 3jvs, 3nlb, 3ot3, 3ot8, 3pa3, 3pa4, 3pa5, 3tkh, 3tki, 3u9n, 4fsm, 4fsn, 4fsq, 4fsr, 4fst, 4fsu, 4fsw, 4fsy, 4fsz, 4ft0, 4ft3, 4ft5, 4ft7, 4ft9, 4fta, 4ftc, 4fti, 4ftj, 4ftk, 4ftl, 4ftm, 4ftn, 4fto, 4ftq, 4ftr, 4ftt, 4ftu, 4gh2, 4hyh, 4hyi, 4jik, 4qye, 4qyf, 4qyg, 4qyh, 4rvk, 4rvl, 4rvm, 5dls, 5f4n, 5fcf, 5fck, 6fc8, 6fcf, 6fck, 7bko, 8e80, 8e81 - hChk1 kinase domain + inhibitor
- 5oot, 5op2, 5op4, 5op5, 5op7, 5opb, 5opr, 5ops, 5opu, 5opv, 5oq5, 5oq6, 5oq7, 5oq8, 7bjd, 7bjh, 7bjj, 7bjm, 7bjo, 7bjr, 7bjx, 7bk1, 7bk2, 7bk3, 7mck, 7suf, 7sug, 7suh, 7sui, 7suj, 8siv, 8siw, 8six - hChk1 kinase domain (mutant) + inhibitor
- 5oop - hChk1 kinase domain (mutant) + AMPPNP
- 5oor - hChk1 kinase domain (mutant) + staurosporine
- 7bkn - hChk1 kinase domain + adenine
- 7bje - hChk1 kinase domain (mutant) + adenine
- 2jqi – yChk1 – yeast
Chk2 (Checkpoint kinase)
- 1gxc – hChk2 phosphothreonine-binding domain + phosphopeptide
- 2cn5 – hChk2 kinase domain + ADP
- 2cn8 – hChk2 kinase domain + inhibitor
- 2cn8, 2uv2, 2w0j, 2w7x, 2wtc, 2wtd, 2wti, 2wtj, 2xbj, 2xk9, 2xm8, 2xm9, 2ycf, 2ycq, 2ycr, 2ycs, 2yiq, 2yir, 2yit, 4a9r, 4a9s, 4a9t, 4bda, 4bdb, 4bdc, 4bdd, 4bde, 4bdf, 4bdg, 4bdh, 4bdi, 4bdj, 4bdk - hChk2 kinase domain + inhibitor
- 3i6u, 3i6w – hChk2 residues 84-502 (mutant)
Chk3 (Mst2); domains - kinase 13-313; SARAH 436-484
- 3wws, 4hkd, 4l0n, 4oh9 – hChk3 SARAH domain
- 4lg4 – hChk3 kinase domain
- 4lgd – hChk3 kinase domain + RASSF5 SARAH domain
- 6ao5 – hChk3 kinase+SARAH domains (mutant) + SAV1 SARAH domain
- 5dh3, 8a66 – hChk3 kinase domain + inhibitor
Chk4 (Mst1) ; Domains – kinase 1-311; SARAH 432-480
- 3com – hChk4 kinase domain
- 6yat, 8a5j– hChk4 kinase domain + inhibitor
- 4nr2 – hChk4 SARAH domain
- 2jo8 – hChk4 SARAH domain - NMR
- 4oh8 – hChk4 SARAH domain + Ras association domain-containing protein
Chk5 (Aurora kinase b)
- 4af3 – hChk5 + inhibitor
Chk6 or Chk15 or Aurora kinase A
- 1mq4, 1muo, 4j8n, 4o0s, 6cpe – hChk6 kinase domain
- 4bn1, 4o0w, 4o0u – hChk6 kinase domain (mutant)
- 5dnr, 5drd, 5dt3 – hChk6 kinase domain + ATP
- 5drd – hChk6 kinase domain + ATP
- 1ol6 – hChk6 kinase domain (mutant) + ATP
- 2wqe – hChk6 kinase domain (mutant) + ADP
- 5odt – hChk6 kinase domain (mutant) + ADP + TACC3
- 2c6d – hChk6 kinase domain (mutant) + ADPNP
- 2dwb – hChk6 kinase domain + AMPPNP
- 6cpf – hChk6 kinase domain + AMPPCP
- 5g15 – hChk6 kinase domain + AMPPNP + monobody
- 6cpg, 8ssp – hChk6 kinase domain + inhibitor + monobody
- 2j4z, 2j50, 2np8, 2x81, 2x6d, 2x6e, 3efw, 3myg, 3vap, 3w10, 3w16, 3w18, 3w2c, 4b0g, 4byi, 4byj, 4j8m, 4jai, 4jaj, 4uyn, 4uzd, 4uzh, 4zs0, 4ztq, 4ztr, 4zts, 5aad, 5aae, 5aag, 5dpv, 5dr6, 5dr9, 5dt0, 5ew9, 5obr, 5one, 5zan, 6c2r, 6c2t, 6gra, 6z4y, 7ayh, 7ayi, 7fic, 7o2v, 8jmx – hChk6 kinase domain + inhibitor
- 2bmc, 2c6e, 2wtw, 2xne, 2xng, 2xru, 3coh, 3fdn, 3h0y, 3h0z, 3h10, 3lau, 3k5u, 3m11, 3nrm, 3p9j, 3r21, 3r22, 3qbn, 3unz, 3uo4, 3uo5, 3uo6, 3uod, 3uoh, 3uoj, 3uok, 3uol, 3up2, 3up7, 4dea, 4deb, 4ded, 4dee, 4dhf, 4jbo, 4jbp, 4jbq, 4prj, 5aad, 5aae, 5aaf, 5aag, 5dpv, 6hjj, 6hjk – hChk6 kinase domain (mutant) + inhibitor
- 5dt4, 5obj – hChk6 kinase domain + ATP + inhibitor
- 5dos, 5dr2 – hChk6 kinase domain (mutant) + ATP + inhibitor
- 5dn3, 5dos, 5dt4, 5obj – hChk6 kinase domain + ATP + inhibitor
- 6c83 – hChk6 kinase domain + AMPPCP + nanobody
- 8sso – hChk6 kinase domain + drug + monobody
- 5dr2 – hChk6 kinase domain (mutant) + ATP + inhibitor
- 5g1x, 7ztl – hChk6 kinase domain (mutant) + N-Myc
- 8guw – hChk6 kinase domain/activator peptide
- 5l8j, 5l8k, 5l8l – hChk6 kinase domain (mutant) + new antigen receptor variable domain
- 5lxm – hChk6 kinase domain (mutant) + Targeting protein for XKLP2
- 3d14, 3d15, 3d2i, 3d2k 3daj, 3dj5, 3dj6, 3dj7 – Chk6 kinase domain (mutant) + inhibitor - mouse
Chk6 with phosphorylated Thr 287, Thr288
- 1ol5, 1ol7 – hChk6 kinase domain + PThr + ADP
- 5dnr, 5dt3 – hChk6 kinase domain + PThr + ATP
- 2w1c, 2w1d, 2w1e, 2w1f, 2w1g, 5dn3 – hChk6 kinase domain + PThr + inhibitor
- 2wtv, 5orl, 5orn, 5oro, 5orp, 5orr, 5ors, 5ort, 5orv, 5orw, 5orx, 5ory, 5orz, 5os0, 5os1, 5os2, 5os3, 5os4, 5os5, 5os6, 5osd, 5ose, 5osf – hChk6 kinase domain (mutant) + PThr + inhibitor
- 3e5a, 3ha6 – hChk6 kinase domain + PThr + inhibitor + targeting protein for XKLP2
- 5g1x – hChk6 kinase domain (mutant) + PThr + N-Myc
- 5l8j, 5l8k, 5l8l – hChk6 kinase domain (mutant) + PThr + new antigen receptor variable domain
- 5lxm – hChk6 kinase domain (mutant) + PThr + TPX2
- 6r4a, 6r4b, 6r4c, 6r4d – hChk6 kinase domain + PThr + inhibitor + ADP
- 6i2u – hChk6 kinase domain (mutant) + PThr + inhibitor + ADP
- 6r49 – hChk6 kinase domain (mutant) + PThr + CoA
Chk10 (lymphocyte-oriented kinase) or LOK or STK10
- 7qgp – hChk10
- 2j7t, 4aot, 4equ, 4usd, 4use, 5ajq, 5owq, 5owr, 6eim, 6gtt, 6hxf, 6i2y – hChk10 kinase domain + inhibitor
- 4bc6, 6i2y – hChk10 + drug
Chk11
- 2wtk – hChk11 (mutant) + calcium-binding protein
Chk12-A (Aurora kinase b-a or Aurora B kinase)
- 2vgo, 2vgp, 2vrx, 3ztx, 4c2v, 5eyk – fChk12-A + inner centromere protein A peptide + inhibitor - frog
- 4c2w – fChk12-A + inner centromere protein A peptide + AMPPNP
- 4b8l, 4b8m, 5k3y – fChk12-A (mutant) + inner centromere protein A peptide + inhibitor
Chk13 (Polo-like kinase Plk)
Plk1 Polo-box domain (Pbd) 371-594
- 1q4o, 2ogq, 3hih, 3p2w, 4h5x, 6n46 – hPlk1 Pbd
Plk1 Pbd complex with polypeptide
- 1umw, 2ojx, 3bzi, 3c5l, 3rq7, 4dfw, 4rcp, 4o6w, 4o56, 4whh, 4whk, 4whl, 5dms, 5dmv, 5dnj , 7mso, 7mx1 – hPlk1 + peptide
- 3hik, 3fvh, 3p2z, 3p34, 3p35, 3p36, 3p37, 3q1i, 4e67, 4e9c, 4e9d, 4hab, 4hy2, 4o9w, 4x9r, 4x9v, 4x9w, 5j19, 6gy2 – hPlk1 + phosphopeptide
- 1q4k – hPlk1 (mutant) + phosphopeptide
- 2v5q – hPlk1 + design ankyrin repeat protein
- 4lkl – hChk Plk1 + PL-55
- 4lkm – hChk Plk1 + PL-74
- 6ax4 – hChk Plk1 + histidine cyclized macrocycle
- 5x3s – mPlk1 + phosphopeptide
- 8joq, 8joy – hPlk1 Pbd + hpv peptide
Plk1 Pbd complex with small molecule inhibitor
- 4h71, 4hco, 5ta6, 5ta8, 8bjt, 8crc – hPlk1 + inhibitor
- 2rku – hPlk1 (mutant) + inhibitor
- 3db6, 3db8, 3dbc, 3dbd, 3dbe, 3dbf – zfPlk1 (mutant) + inhibitor – zebra fish
Plk1 catalytic domain 36-345
- 2owb – hPlk1 catalytic domain (mutant)
- 2ou7 – hPlk1 catalytic domain (mutant) + AM
- 2yac, 3kb7, 3thb, 4a4l, 4a4o – hPlk1 catalytic domain + inhibitor
- 3fc2 – hPlk1 catalytic domain (mutant) + inhibitor
- 4j52, 4j53 – hChk Plk1 (mutant) + inhibitor
- 3d5x – zfPlk1 catalytic domain (mutant) + wortmannin
- 3d5w – zfPlk1 catalytic domain + ADP
Plk2
- 4i5m, 4i5p, 4i6b, 4i6f, 4i6h – hChk Plk2 kinase domain (mutant) + inhibitor
- 4rs6, 4xb0 – hChk Plk2 Pbd
Plk3
- 4b6l, 4i6b – hChk Plk3 kinase domain + inhibitor
Plk4; Domains – kinase 2-275; Pbd 580-808; Pb3 884-970
- 3cok – hChk Plk4 kinase domain
- 4n9j – hChk Plk4 Pbd domain
- 4n7v, 4n7z – hChk Plk4 Pbd domain + centrosomal protein
- 6w38, 6w3i – hChk Plk4 Pbd domain + Fam46C
- 6w3j – hChk Plk4 Pbd domain + Fam46C + CEP92 peptide
- 4jxf, 4yur – hChk Plk4 kinase domain + inhibitor
- 5lhy – hChk Plk4 Pb3 domain
- 4yyp, 5lhz – hChk Plk4 Pb3 domain + Scl-interrupting locus protein
- 4g7n, 4nk7, 5lhx, 7rl3 – DmChk Plk4 Pbd domain – Drosophila melanogaster
Chk16
- 2buj – hChk16 (mutant) + staurosporin
Chk17B or DRAK2 or STK17B
- 3lm0 – hChk17B
- 6qf4, 7q7c, 7q7d – hChk17B + ADP
- 7q7e – hChk17B + ATP
- 3lm5 – hChk17B + quercetin
- 6y6f, 6y6h, 6zjf – hChk17B + pyrimidine derivative
- 7akg – hChk17B + drug
Chk19 or STK19
- 7xrb – hChk19
Chk24 (Mst3) or STK24
- 3a7f, 3a7g, 3a7h, 3a7i, 3a7j, 3ckw – hChk24 kinase domain
- 4qmm, 4qmn, 4qmo, 4qmp, 4qmq, 4qms, 4qmt, 4qmu, 4qmv, 4qmw, 4qmx, 4qmy, 4qmz, 4qna, 4qo9, 4u8z, 4w8d, 4w8e, 7b30, 7b31, 7b32, 7b33, 7b34, 7b35, 8bzi, 8bzj, 8qlr, 8qls, 8qlt – hChk Mst3 + inhibitor
- 8qlq – hChk Mst3 + macrocyclic inhibitor
- 3ckx – hChk24 kinase domain + staurosporin
- 3zhp – hChk24 kinase domain + calcium-binding protein
- 4o27 – hChk24 kinase domain (mutant) + calcium-binding protein
- 4qml – hChk Mst3 kinase domain + AMPPNP
Chk25 or STK25
- 2xik – hChk25 kinase domain
- 7z4v – hChk25 kinase domain + inhibitor
- 3w8h – hChk25 regulatory domain + programmed cell death protein 10
- 4nzw – hChk25 kinase domain (mutant) + calcium-binding protein
Chk26 (Mst4)
- 3ggf, 7b36 – hChk Mst4 + inhibitor
- [[[3w8i|3w8i]], [4geh]] - hChk Mst4 dimerization domain + programmed cell death protein 10
- 4fza, 4fzd, 4fzf – hChk Mst4 (mutant) + calcium-binding protein
Chk32
- 4fr4 – hChk32A
Chk38
- 6bxi – hChk38 kinase domain
Chk39 or SPAK
- 7o86 – hChk39 C-terminal
- 5d9h – mChk39 residues 63-403 + ATP
- 5dbx – mChk39 residues 63-403 (mutant) + AMPPNP
Chk40
- 5l2q – hChk40 kinase homology domain
Dclk1
- 6kyq – hChk Dclk1 kinase domain
- 6kyr – hChk Dclk1 kinase domain (mutant)
- 5jzj – hChk Dclk1 kinase domain + AMPPN
- 5jzn, 7kx6, 7kxw – hChk Dclk1 kinase domain + inhibitor
- 7f3g – hChk Dclk1 kinase domain + drug
- 7kx8 – hChk Dclk1 C-terminal + inhibitor
Rac-α hChk (AKT1); domains: pleckstrin homology 1-123; kinase 144-480
- 1unp, 1unr – hRac-α hChk pleckstrin homology domain
- 2uzr, 2uzs, 7myx – hRac-α hChk pleckstrin homology domain (mutant)
- 1h10, 1unq, 2uvm – hRac-α hChk pleckstrin homology domain + inositol tetrakisphosphate
- 3o96, 4ejn, 6hhf, 6hhg, 6hhh, 6hhi, 6hhj, 6s9w, 6s9x - hRac-α hChk + inhibitor
- 5kcv, 7nh4, 7nh5 - hRac-α hChk (mutant) + inhibitor
- 4ekl, 4gv1 - hRac-α hChk kinase domain + inhibitor
- 3qkm, 6ccy - hRac-α hChk kinase domain (mutant) + inhibitor
- 6buu - hRac-α hChk kinase domain + bisubstrate peptide
- 4ekk - hRac-α hChk kinase domain (mutant) + GSK3 peptide + AMPPNP
- 6npz - hRac-α hChk kinase domain + peptide + inhibitor
- 3ow4, 3qkk, 3qkl, 6buu - hRac-α hChk kinase domain (mutant) + peptide + inhibitor
- 7apj - hRac-α hChk + nanobody
Rac-β hChk (AKT2)
- 1gzk, 1gzn, 1gzo, 1mrv, 1mry – hRac-β hChk kinase domain
- 1p6s - hRac-β hChk pleckstrin homology domain - NMR
- 1o6k - hRac-β hChk kinase domain + GSK3 peptide + AMPPNP
- 2jdo, 2jdr, 2uw9, 2x39, 3cqu, 3cqw - hRac-β hChk kinase domain + GSK3 peptide + inhibitor
- 3e87, 3e88, 3e8d - Rac-β hChk kinase domain (mutant) + GSK3 peptide + inhibitor<br /
- 1o6l - hRac-β hChk kinase domain (mutant) + GSK3 peptide + AMPPNP
- 3d0e, 8q61 - hRac-β hChk kinase domain (mutant) + inhibitor
Rac-γ hChk (ATK3)
- 2x18 – Rac-γ hChk PH domain
A-Raf
- 1wxm – hA-Raf RAS-binding domain 19-91 - NMR
- 2mse – hA-Raf RAS-binding domain + APOA-I + K-ras - NMR
B-Raf; domains - BRS 38-116; Ras-binding 153-237; kinase 445-723
- 8dgs, 8dgt – hB-Raf in Ras/Raf complex – Cryo EM
- 7z37, 7z38, 7zr5 – hB-Raf + Hsp90 + CDC37 + PP5 – Cryo EM
- 1uwh, 3c4c, 6v2u, 6xfp, 6xlo, 8f7o, 8f7p – hB-Raf kinase domain + anticancer drug
- 1uwj, 6p3d – hB-Raf kinase domain (mutant) + anticancer drug
- 2fb8, 3d4q, 3e26, 3ii5, 3ppj, 3ppk, 3prf, 3pri, 3psb, 3psd, 3q4c, 3q96, 3skc, 3tv4, 3tv6, 4dbn, 4e26, 4e4x, 4ehe, 4fc0, 4g9c, 4h58, 4ksp, 4ksq, 4mbj, 4pp7, 6cad, 7shv – hB-Raf kinase domain + pyrazole inhibitor
- 3idp, 4ehg, 4fk3, 4g9r, 4jvg, 4mnf, 4r5y, 4rzv, 4rzw, 4wo5, 4xv1, 4xv2, 4xv3, 4xv9, 4yht, 5c9c, 5hi2, 5ita, 5jrq, 5jsm, 5jt2, 6nsq, 6p7d, 6uuo – hB-Raf kinase domain (mutant) + pyrazole inhibitor
- 5csw, 5csx, 5ct7, 5fd2, 5hid, 5hie, 5val, 5vam, 6b8u, 6n0p, 6n0q, 7k0v, 7p3b, 7p3v, 8c7x, 8c7y - hB-Raf kinase domain + inhibitor
- 6v34 – hB-Raf kinase domain (mutant) + inhibitor
- 4mne – hB-Raf kinase domain + MAPKK1
- 8f7o – hB-Raf kinase domain + drug
- 7m0u – hB-Raf kinase domain + AMPPNP + drug
- 6u2h – hB-Raf kinase domain + 14-3-3 ζ/δ
- 7mfe – hB-Raf + 14-3-3 ζ/δ – Cryo EM
- 7mff – hB-Raf + 14-3-3 ζ/δ + inhibitor – Cryo EM
- 7mfd – hB-Raf + 14-3-3 ζ/δ + MEK + inhibitor – Cryo EM
- 6pp9 – hB-Raf kinase domain + MEK1 + ANP
- 7m0x, 7m0z – hB-Raf kinase domain + MEK1 + ANP + inhibitor
- 7m0t, 7m0u, 7m0v, 7m0w, 7m0y – hB-Raf kinase domain + MEK1 + ANP + drug
- 6u2g – hB-Raf kinase domain + MEK1 + AMPPCP
- 5vr3 – hB-Raf BRS domain
- 7jhp – hB-Raf BRS domain + Hras
- 6ntc, 6ntd – hB-Raf BRS domain (mutant) + Hras
- 6xi7 – hB-Raf 52-188 + Kras
- 2l05, 5j17, 5j2r – hB-Raf RAS-binding domain - NMR
- 3ny5 – hB-Raf RAS-binding domain
- 5j18 – hB-Raf RAS-binding domain + inhibitor - NMR
- 6pts, 6ptw – hB-Raf 56-187 + Kras + apolipoprotein + GMPPNP - NMR
- 6q0k, 6uan – hB-Raf + 14-3-3 ζ – Cryo EM
- 6nyb – hB-Raf + 14-3-3 ζ + MEK1 – Cryo EM
- 6q0t, 6q0j – hB-Raf (mutant) + 14-3-3 ζ + MEK1 – Cryo EM
c-Raf; Domains – RAS-binding (RBD) 55-132; Cys-rich 136-187 (CBD); kinase 323-618
- 1rfa, 8jna, 8jof, 8jog – hc-Raf RBD - NMR
- 1faq, 1far – hc-Raf cysteine-rich domain - NMR
- 3omv – hc-Raf kinase domain
- 1rrb – c-Raf RBD – NMR - rat
c-Raf complex with protein
- 8cpd – hc-Raf + 14-3-3 protein zeta – Cryo EM
- 9mmp – hc-Raf + MEK1 + 14-3-3 protein zeta – Cryo EM
- 9mmr – hc-Raf (mutant) + MEK1 + 14-3-3 protein zeta – Cryo EM
- 1c1y – hc-Raf RBD + RAP1A
- 3kuc – hc-Raf RBD (mutant) + RAP1A
- 1gua – hc-Raf RBD + RAP1A + GPPNHP
- 8jnb – hc-Raf RBD + ligand
- 4g0n, 4g3x – hc-Raf RBD + GTPase Hras
- 3kud – hc-Raf RBD (mutant) + GTPase Hras
- 8epw, 8t74 – hc-Raf RBD + GTPase K-ras
- 8t75, 9ygs – hc-Raf RBD-CRD + GTPase K-ras + GMPPNP
- 9ay7, 9aya – hc-Raf + MEK1
- 9mmq – hc-Raf + MEK1 – Cryo EM
- 9mms – hc-Raf (mutant) + MEK1 – Cryo EM
- 9o0u, 9o0v – hc-Raf (mutant) + MEK1 + ANP + inhibitor– Cryo EM
- 8u1l – hc-Raf + Hsp90 + CDC37 – Cryo EM
- 8gae, 8gft – hc-Raf + Hsp90 + CDC37 + PP5 – Cryo EM
Snf1-related Chk
- 3uc4, 3uc3, 3udb, 3zut, 3zuu – AtChk Srk2E kinase domain (mutant) – Arabidopsis thaliana
- 3ujg – AtChk Srk2E kinase domain (mutant) + protein phosphatase 2C
- 5yks – hChk
MAPK-interacting Chk or Mnk1 Mnk2
- 2hw6 – hMnk 1 catalytic domain
- 2hw7 – hMnk 1 catalytic domain + staurosporin
- 5wvd – hMnk 1 catalytic domain + inhibitor
- 2ac3 – hMnk 2 catalytic domain
- 2ac5 – hMnk 2 catalytic domain (mutant)
- 6cj5, 6cje, 6cjh, 6cjw, 6cjy, 6ck3, 6ck6, 6cki – hMnk 2 catalytic domain (mutant) + inhibitor
hChk Pak or Chk N or PRK1; Domains - CRIB 74-109; Hr1B 122-199; catalytic 109-426; kinase 605-942
- 1urf – hChk Pak-1 Hr1b domain - NMR
- 4nkg – hChk Pak-1 Hr1b domain + SSPH1 LRR domain
- 2rmk – hChk Pak-1 Hr1bb domain + Rac1 - NMR
- 1f3m – hChk Pak-1 autoregulatory+kinase domains
- 4otd - hChk Pak-1 kinase domain
- 1yhv, 1yhw, 3q4z, 3q52, 3q53 – hChk Pak-1 kinase domain (mutant)
- 4o0r, 4o0t, 4zji, 4zjj, 4zlo, 4zy4, 4zy5, 4zy7, 5ime, 5kbq, 5kbr, 6b16, 7vto – hChk Pak-1 kinase domain + inhibitor
- 4oti, 4oth, 4otg – hChk Pak-1 kinase domain + inhibitor
- 4eqc, 4p90, 5dew, 5dey, 5dfp – hChk Pak-1 kinase domain (mutant) + inhibitor
- 2hy8 – hChk Pak-1 kinase domain + staurosporin
- 2qme – hChk Pak-1 CRIB domain + RAC3
- 3fxz, 3fy0, 4daw – hChk Pak-1 kinase domain (mutant) + Ru complex
- 6fd3 – hChk Pak-3 kinase domain (mutant)
- 2j0i, 4fie – hChk Pak-4
- 4fig, 4fij, 4l67 – hChk Pak-4 kinase domain
- 2cdz – hChk Pak-4 + purine derivative
- 2ov2 – hChk Pak-4 CRIB domain + RAC3
- 2qon, 4fif, 4fih, 4fii, 4jdh, 4jdi, 4jdj, 4jdk, 6wlx, 6wly – hChk Pak-4 kinase domain + peptide
- 4app, 4o0v, 4o0x, 4o0y, 4njd, 4xbu, 5bms, 5i0b, 5vee, 5vef, 5zjw, 5xvg, 5xvf, 5xva, 7cmb, 7cp3, 7cp4 – hChk Pak-4 kinase domain + inhibitor
- 2x4z, 2xh5 – hChk Pak-4 kinase domain (mutant) + inhibitor
- 5upl, 5upk – hChk Pak-4 kinase domain (mutant) + CDC42
- 5ved – hChk Pak-4 kinase domain + staurosporine
- 8ahi – hChk Pak-4 300-591 + inhibitor
- 7s46, 7s48 – hChk Pak-4 catalytic domain + integrin beta-5 peptide
- 2c30 – hChk Pak-6
- 2odb – hChk Pak-6 CRIB domain + CDC42
- 4ks8 – hChk Pak-6 kinase domain + sunitinib
- 4ks7 – hChk Pak-6 kinase domain (mutant) + inhibitor
- 2f57 – hChk Pak-7
Mycobacterium tuberculosis Chk Pkn
- 4x3f - MtChk PknA – Mycobacterium tuberculosis
- 4ow8 - MtChk PknA kinase domain
- 3ori, 3ork, 3orl, 3orm, 3oro, 3orp, 3ort - MtChk PknB kinase domain (mutant)
- 1o6y – MtChk PknB kinase domain
- 6b2p, 6b2q – MtChk PknB kinase domain + inhibitor
- 2kud, 2kue, 2kuf, 2kui – MtChk PknB pasta domains 2-3 - NMR
- 3ouv – MtChk PknB pasta domain 3
- 5e0y – MtChk PknB pasta domain 4
- 5e10 – MtChk PknB pasta domains 1-2
- 5e0z – MtChk PknB pasta domains 3-4
- 5e12 – MtChk PknB pasta domains 2-4
- 5u94 - MtChk PknB kinase domain + inhibitor
- 3f61, 3f69 - MtChk PknB kinase domain (mutant) + inhibitor
- 6i2p - MtChk PknB kinase domain (mutant) + GARA + peptide
- 1rwi, 1rwl - MtChk PknD extracellular domain
- 2h34 – MtChk PknE catalytic domain
- 7naa – MtChk PknF kinase domain + inhibitor
- 4y12 - MtChk PknG + ATP-gS
- 4y0x - MtChk PknG + ADP
- 7q52 - MtChk PknG + inhibitor
- 4esq - MtChk PknH extracellular domain
- 5m06, 5xka - MtChk PknI kinase domain
- 5m07, 5m08, 5m09 - MtChk PknI kinase domain (mutant)
- 5xlm, 5xll - MtChk PknI sensor domain
- 7mxb, 7mxj, 7mxk - Chk PknG kinase domain + AMPPNP - Corynebacterium glutamicum
hChk Nek
- 4apc – hChk Nek1 kinase domain (mutant)
- 4b9d - hChk Nek1 kinase domain (mutant) + inhibitor
- 2w5h – hChk Nek2 kinase domain
- 2jav, 2wqo, 2xk3, 2xk4, 2xk6, 2xk7, 2xk8, 2xkc, 2xkd, 2xke, 2xkf, 2xnm, 2xnn, 2xno, 2xnp, 4a4x, 4afe, 5m51, 5m53, 5m55, 5m57, 6sgd, 6sgh, 6sgi, 6sgk, 6sk9 – hChk Nek2 + inhibitor
- 2w5a, 2w5b – hChk Nek2 + nucleotide
- 6tm5 - hChk Nek2 in anaphase-promoting complex – Cryo EM
- 2wqm, 6s76 – hChk Nek7
- 2wqn – hChk Nek7 + ADP
- 5de2 – hChk Nek7 + hChk Nek9
- 6s73, 2wqo – hChk Nek7 + inhibitor
- 6npy – hChk Nek7 + Nlrp3
- 6s75 – hChk Nek7 + inhibitor
Chk Rio
- 6fdo, 6fdn, 6fdm – hChk Rio2
- 4otp – hChk Rio1 Rio domain + ADP
- 6hk6, 7vbt – hChk Rio2 + inhibitor
- 6eml, 6fai, 6g18, 6g51, 6rbd,6rbe, 6y7c – yChk Rio2 in 40S particle – Cryo EM
- 1ztf – AfChk Rio1 + adenine derivative – Archaeoglobus fulgidus
- 1zth – AfChk Rio1 + ADP
- 1zp9 – AfChk Rio1 + ATP
- 1tqp, 1zao – AfChk Rio2 + ATP
- 1zar – AfChk Rio2 + ADP
- 4gyg – CtChk Rio2 – Chaetonium thermophilum
- 4gyi – CtChk Rio2 + ADP
hChk Vrk (vaccinia-related kinase)
- 2kty, 2kul, 2lav, 2rsv – hChk Vrk1 kinase domain 1-396 - NMR
- 3op5 – hChk Vrk1 kinase domain (mutant)
- 5ukf – hChk Vrk1 kinase domain + inhibitor
- 5uvf, 6cnx, 6bu6, 6cfm, 6dd4, 6bp0, 6bru, 6btw, 6cmm, 6cqh, 6csw, 6npn, 6vxu, 6vzh – hChk Vrk1 kinase domain (mutant) + inhibitor
- 6ac9 – hChk Vrk1 kinase domain (mutant) + AMPPNP
- 7tan – hChk Vrk1 kinase domain + nucleosome – Cryo EM
- 2v62 – hChk Vrk2 kinase domain
- 5uu1, 6ncg, 8q1z – hChk Vrk2 kinase domain + inhibitor
Chk Wnk (protein kinase lysine-deficient); Domains - kinase 194-483; CCT1 454-549
- 6cn9, 4q2a, 4pwn - hChk Wnk1 kinase domain (mutant)
- 5tf9 - hChk Wnk1 kinase domain + inhibitor + AMPPNP
- 5wdy, 5we8 - hChk Wnk1 kinase domain + inhibitor + ANP
- 5drb, 6ol2- rChk Wnk1 kinase domain (mutant) + inhibitor
- 6elm - hChk Wnk2 CCT1 domain
- 6fbk - hChk Wnk2 CCT1 domain + Wnk1 peptide
- 5o1v, 5o21, 5o23 - hChk Wnk3 kinase domain
- 5o2c - hChk Wnk3 kinase + CCT1 domains
- 5o26, 5tf9 - hChk Wnk3 kinase domain + AMPPNP
- 5o2b - hChk Wnk3 kinase domain + inhibitor
- 8edh - hChk Wnk3 kinase domain (mutant) + inhibitor
- 2lru – rChk Wnk1 autoinhibitory domain 480-572 - NMR
- 5w7t - rChk Wnk1 kinase domain
- 7uos - rChk Wnk1 kinase domain (mutant)
TANK-binding kinase
- 4efo – hChk Tbk1 ubiquitin-like domain
- 6rsr, 6rsu – hChk Tbk1 + inhibitor
- 4im0, 4im2, 4im3, 4iw0, 4iwo, 4iwp, 4ipq, 6rst – hChk Tbk1 (mutant) + inhibitor
- 6cq5, 6cq4, 6cq0, 6boe, 6bod, 6bny, 5w5v – hChk Tbk1 + ulcer drug
- 4eut, 4euu – hChk Tbk1 kinase+ubiquitin-like domains (mutant) + inhibitor
- 6nt9 – hChk Tbk1 (mutant) + STING
- 5eoa, 5eof – hChk Tbk1 residues 677-729 + optineurin
- 4jl9, 4jlc – mChk Tbk1 + inhibitor
- 6o8c, 6o8b – mChk Tbk1 (mutant) + STING
Haspin
- 2vuw, 2wb8 – hChk Haspin kinase domain
- 3dle – hChk Haspin kinase domain + AMP
- 3e7v, 3f2n, 3fmd, 3iq7, 4qtc, 5htb, 5htc, 6z56, 6z57, 6z58, 6z59, 6z5a, 6z5b, 6z5c. 6z5d, 6z5e , 7avq, 7ops – hChk Haspin kinase domain + inhibitor
- 7sqm – hChk Haspin kinase domain + antimalarial
- 6g38, 6g34, 6g35, 6g36, 6g37 – hChk Haspin kinase domain + tubercidin derivative
- 6g39, 6g3a – hChk Haspin kinase domain (mutant) + tubercidin derivative
- 4ouc – hChk Haspin kinase domain + histone H3 peptide
MAP/microtubule affinity-regulating kinase (MARK)
- 2hak – hChk MARK1 catalytic+UBA domains
- 3ose - hChk MARK1 KA1 domain
- 6c9d – hChk MARK1 catalytic+UBA+KA1 domains (mutant)
- 5eak, 5kz7, 5kz8 – hChk MARK2 catalytic+UBA domains + inhibitor
- 3iec – hChk MARK2 catalytic+UBA domains + cytotoxicity-associated immunodominant antigen peptide
- 2qnj – hChk MARK3 catalytic+UBA domains
- 3fe3 – hChk MARK3 catalytic+UBA domains (mutant)
- 7p1l – hChk MARK3 catalytic+UBA domains + inhibitor
- 5es1 – hChk MARK4 catalytic+UBA domains + inhibitor
- 1zmu – rChk MARK2 catalytic+UBA domains
- 2wzj, 2r0i, 1zmv, 1y8g, 1zmw – rChk MARK2 catalytic+UBA domains (mutant)
- 1ul7, 1v5s - mChk MARK3 catalytic domain - NMR
Mitotic checkpoint Chk (Bub); Domains: TPR 1-220; kinase 726-1085
- 2lah – hChk Bub1 TPR domain – NMR
- 2wvi – hChk Bub1β TPR domain
- 3si5 – hChk Bub1 TPR domain + CASC5 peptide
- 4r8q, 4qpm, 5dmz – hChk Bub1 kinase domain + ADP
- 6f7b – hChk Bub1 kinase domain + inhibitor
- 4a1g – hChk Bub1 TPR domain + CASC5 KI motif
- 4ggd - hChk Bub1 + cell division cycle protein
- 6tlj, 5khu - hChk Bub1 in anaphase-promoting complex – Cryo EM
- 6jkk – DmChk Bub1 kinase domain
- 6jkm – DmChk Bub1 kinase domain + ADP
- 5jja – hChk Bub1 residues 661-734 + PP2A
- 3esl – yChk Bub1 N terminal
- 4bl0 - yChk Bub1 + cell cycle arrest protein Bub3
Microtubule-associated Chk
- 2m9x – hChk 1 residues 187-287 – NMR
- 3ps4 - hChk 1 residues 965-1057
- 2kqf, 2kyl – hChk 2 PDZ domain + glycoprotein C terminal – NMR
- 3khf - hChk 3 PDZ domain
- 2w7r – hChk 4 PDZ domain
mTOR or Mechanistic target of rapamycin
mTOR FRB domain residues 2015-2114
- 1nsg, 1fap – hFRAP FRB domain + FKBP
- 2rse – hFRAP FRB domain + FKBP – NMR
- 1aue – hFRAP FRB domain
- 2gaq, 2npu – hFRAP FRB domain - NMR
- 8ppz – hFRAP FRB domain + FKBP + pyridine derivative
- 3fap, 2fap, 4fap – hFRAP FRB domain + FKBP + rapamycin analog
- 4drh, 4dri, 4drj, 5gpg – hFRAP FRB domain + FKBP + rapamycin
- 6m4u, 6m4w – hChk Mtor FRB domain (mutant) + FKBP1A + rapamycin
- 5wbh – hFRAP FRB domain + S6K1 peptide
mTOR FAT+PIKK domain residues 1376-2549
- 4jsn – hFRAP + TORC subunit LST8
- 4jsp – hFRAP + TORC subunit LST8 + ATP
- 4jsv – hFRAP + TORC subunit LST8 + ADP
- 4jsx – hFRAP + TORC subunit LST8 + torin2
- 4jt5 – hFRAP + TORC subunit LST8 + pp242
- 4jt6 – hFRAP + TORC subunit LST8 + PI-103
- 5wby, 5wbu – hFRAP + TORC subunit LST8 + proline-rich Akt1 substrate
mTOR complex
- 5flc – hmTOR + RAPTOR + LST8 + FKBP – Cryo EM
- 5h64 – hmTOR + RAPTOR + LST8 – Cryo EM
- 6sb2 – hChk Mtor + RAPTOR + LST8 + RAGA + RAGC – Cryo EM
- 6sb0 – hChk Mtor + RAPTOR + LST8 + RAGA + RAGC + proline-rich Akt1 substrate – Cryo EM
- 5zcs – hmTOR + LST8 + AVO3 + TORC2 – Cryo EM
- 7tzo – hTORC2 in mTORC2 complex– Cryo EM
- 6zwm, 6zwo, 7owg, 7pe7, 7pe8, 7pe9, 7pea, 7peb, 7pec, 7uxc , 8era– mTOR in mTor complex – Cryo EM
Gcn2
- 1zyc – yChk Gcn2
- 1zxe, 1zy4, 1zy5 – yChk Gcn2 (mutant)
- 2yz0 – yChk Gcn2 RWD/GI domain – NMR
- 4otm – yChk Gcn2 C terminal domain
- 1zyd – yChk Gcn2 + ATP
- 4otn – mChk Gcn2 C terminal domain
LRRK1 or leucine-rich repeat Chk1
- 8e04, 8e05, 8e06, 8fac – hLRRK1 – Cryo EM
LRRK2 or leucine-rich repeat Chk2 or dardarin
- 6xr4 – hLRRK2 – Cryo EM
- 7lht, 7lhw, 7li4 – hLRRK2 + ATP + GDP – Cryo EM
- 7li3 – hLRRK2 (mutant) + ATP + GDP – Cryo EM
- 6oje, 7thy – hLRRK2 GTPase domain 1329-1520
- 6ojf – hLRRK2 GTPase domain (mutant)
- 6dlo, 6dlp – hLRRK2 WD40 domain
- 7thz – hLRRK2 1330-1527 + GDP
- 6vno, 6vp6, 6vp7 – hLRRK2 C terminal 1330-2527 – Cryo EM
- 6vp8 – hLRRK2 C terminal 1330-2527 + COR domain 1670-1950 + WD40 domain 2140-2489 – Cryo EM
- 6s6q – AtLRRK2 ectodomain + protein casparian strip peptide
Pim
Pim1 catalytic domain residues 14-313
- 1xqz, 1ywv, 4jx3 – hPim1 catalytic domain
- 1yxs – hPim1 catalytic domain (mutant)
- 1xr1, 1yxt – hPim1 catalytic domain + AMPPNP
- 1yxu – hPim1 catalytic domain + AMP
- 1yxv, 5ipj – hPim1 catalytic domain + quinoline derivative
- 1yxx – hPim1 catalytic domain + indole derivative
- 2bzh, 2bzi, 2bzj – hPim1 catalytic domain (mutant) + organometallic ligand
- 2o3p, 2o63, 2o64, 2o65, 3c4e, 3jxw, 3jy0, 3jya, 3r00, 3r01, 3r02, 3r04, 3vbq, 3vbt, 3vbv, 3vbw, 3vbx, 3vby, 3vc4, 3umw, 3umx, 4enx, 4eny, 4k1b, 4k18, 4k0y, 4iaa, 4i41, 4ll5, 4lm5, 4lmu, 4mta, 4med, 4mbl, 4mbi, 4n6y, 4n6z, 4n70, 4xh6, 5iis, 5kgd, 5kge, 5kgg, 5kgi, 5kgk, 5kzi, 5vua, 5vub, 5vuc, 6mt0, 6vrv, 7oov, 7oow, 7oox, 7xsv – hPim1 catalytic domain + inhibitor
- 2j2i, 3we8 – hPim1 catalytic domain (mutant)+ inhibitor
Pim1 kinase domain residues 92-404
- 4jx3 – hPim1 kinase domain
- 3uix, 5c1q – hPim1 kinase domain residues 120-404 + quinoline derivative
- 3a99 – hPim1 kinase domain + phosphoaminophosphonic acid adenylate
- 2oi4, 3bwf – hPim1 kinase domain (mutant) + organometallic ligand
- 1xws, 4alu, 4alv, 4alw, 4as0, 4bzn, 4bzo, 4dtk, 4jx7, 4rbl, 4rc2, 4rc3, 4rc4, 4ty1, 4wrs, 4wsy, 4wt6, 4xhk, 5dgz, 5dhj, 5dia, 5dwr, 5eol, 5kcx, 5o11, 5o12, 5o13, 5tel, 5tex, 5toe, 5v80, 5v82. 6bsk, 6kzi, 6l11, 6l12, 6l13, 6l14, 6l15, 6l16, 6l17, 6no8, 6no9, 6vru, 6ykd, 7zun – hPim1 kinase domain + inhibitor
- 6ayd – hPim1 kinase domain (mutant)+ inhibitor
Pim1 full length
- 4rpv, 5tur - hPim1 + inhibitor
Pim1 complex with consensus peptide (pimtide)
- 2bil, 3cxw, 3cy2, 3cy3, 6qxk, 6pcw, 6pdi, 6pdn, 6pdo, 6pdp – hPim1 kinase domain + inhibitor + consensus peptide
- 3jpv, 3qf9 - hPim1 catalytic domain + inhibitor + consensus peptide
- 2c3i, 5ndt, 5n5m, 5n5l, 5n52, 5n51, 5n50, 5n4z, 5n4y, 5n4x, 5n4v, 5n4u, 5n4r, 5n4o, 5n4n, 5mzl – hPim1 kinase domain (mutant) + inhibitor + consensus peptide
- 4gw8, 7qb2, 7qfm, 7z6u, 8afr – hPim1 catalytic domain (mutant) + inhibitor + pimtide
- 2bzk – hPim1 kinase domain (mutant)+ AMPPNP + consensus peptide
- 3ma3 – hPim1 catalytic domain + inhibitor + PSer + consensus peptide
Pim1 containing phosphorylated Ser 261
- 1yhs – hPim1 kinase domain + PSer + staurosporine
- 1yi3, 2bik, 2xix, 2xiy, 2xiz, 2xj0, 2xj1, 2xj2, 4a7c – hPim1 kinase domain + PSer + inhibitor
- 2obj, 3bgp, 3bgq, 3bgz, 3dcv, 3f2a, 3t9i - hPim1 catalytic domain + PSer + inhibitor
- 1yi4 – hPim1 kinase domain + PSer + adenosine
Pim2
- 4x7q – hPim2 catalytic domain + inhibitor
- 2iwi – hPim2 catalytic domain + Ru ligand
Rip or receptor-interacting Chk; Domains – catalytic 1-294; Amyloid fibril 418-518; Death 561-671
- 6ac5 – hRip1 death domain
- 6r5f, 6nw2, 6c4d, 6c3e, 5tx5, 7fcz, 7fd0, 7ydx – hRip1 catalytic domain + inhibitor
- 6rln, 6ocq, 6nyh, 6hho – hRip1 catalytic domain (mutant) + inhibitor
- 6ggs – hRip2 – Cryo EM
- 5yrn – hRip2 CARD domain 434-540 – Cryo EM
- 6szj, 6sze, 6s1f, 6rna, 6rn8, 6hmx, 6fu5, 6es0, 5w5o, 5w5j – hRip2 catalytic domain + inhibitor
- 6ul8 – hRip2 catalytic domain (mutant) + inhibitor
- 8aza – hRip2 catalytic domain + XiaP Bir2 domain – Cryo EM
- 7mx3 – hRip3 catalytic domain (mutant) + inhibitor
- 7mon – hRip3 catalytic domain (mutant) + MLKL
- 7dac – hRip3 amyloid fibril - NMR
- 7da4 – hRip3 amyloid fibril – Cryo EM
- 6oko – mRip3 catalytic domain + inhibitor
- 6jpd – mRip3 residues 409-486 - NMR
- 5wnm, 5wnj – mRip4 catalytic domain (mutant) + drug
- 5wnl – mRip4 catalytic domain (mutant) + staurosporine
- 5wnk – mRip4 catalytic domain (mutant) + inhibitor
- 5wni – mRip4 catalytic domain (mutant) + ATP
- 6gwm – rRip2 caspase recruitment domain 433-539
Ulk
- 6qas – hChk Ulk1 + inhibitor
- 5ci7, 6mnh – hChk Ulk1 (mutant) + inhibitor
- 4wnp, 4wno – hChk Ulk1 + IST1 homolog
- 8soi, 8sqz – hChk Ulk1 + RB1-inducible coiled-coil protein + autophagy-related protein
- 8srm – hChk Ulk1 + RB1-inducible coiled-coil protein + autophagy-related protein – Cryo EM
- 8srq – hChk Ulk1 + RB1-inducible coiled-coil protein + autophagy-related protein + PI3K – Cryo EM
- 6qav, 6qau, 6qat, 6yid – hChk Ulk2 + inhibitor
- 4wzx – hChk Ulk3 MIT 2 domain + inhibitor
- 6fdz, 6fdy – hChk Ulk3 + leukemia drug
- 6tsz – hChk Ulk4 pseudfokinase domain + ATPgS
- 6u5l – hChk Ulk4 (mutant) + inhibitor
Hipa and Hipb
- 3tpd, 3tpe – EcChk Hipa – Escherichia coli
- 3tpb, 3dnt, 3dnu – EcChk Hipa (mutant)
- 4pu7, 4pu8 – SoChk Hipb - Shewanella oneidensis
- 3tpt – EcChk Hipa (mutant) + ADP
- 3fbr – EcChk Hipa (mutant) + AMPPNP + peptide
- 3tpv – EcChk Hipa + ADP
- 2wiu – EcChk Hipa + Hipb
- 4yg7, 5k98, 3hzi, 3dnv – EcChk Hipa + Hipb + DNA
- 4yg1, 4z58, 4z59, 4z5c, 4z5d – EcChk Hipb + DNA
- 4z5h – EcChk Hipb (mutant) + DNA
- 4pu3, 4pu4 – SoChk Hipa + Hipb + DNA - Shewanella oneidensis
- 4pu5 – SoChk Hipa + AMPPNP
Chk Smg
- 6l53 – hChk Smg1 – Cryo EM
- 7pw6 – hChk Smg1 + inhibitor – Cryo EM
- 7pw7 – hChk Smg1 + Smg9 + inhibitor – Cryo EM
- 7pw9 – hChk Smg1 + Smg9 + AMPPNP + ATP – Cryo EM
- 6l54, 6syt – hChk Smg1 + Smg8 + Smg9 – Cryo EM
- 7pw4, 7pw5 – hChk Smg1 + Smg8 + Smg9 + inhibitor – Cryo EM
- 7pw8 – hChk Smg1 + Smg8 + Smg9 + AMPPNP – Cryo EM
- 6z3r – hChk Smg1 + Smg8 + Smg9 + regulator of nonsense transcripts – Cryo EM
- 2hwy – hChk Smg5 PIN domain
- 2hww, 2hwx – hChk Smg6 PIN domain (mutant)
- 4um2 – hChk Smg6 TPR domain
- 1ya0 – hChk Smg7 N terminal
Chk Vprbp or DCAF1
- 4pxw, 8ood – hChk Vprbp WD repeat domain 1039-1401 (mutant)
- 7sse, 7ufv, 8f8e, 8og5, 8og6, 8og7, 8og8, 8og9, 8oga, 8ogb, 8ogc, 8oo5, 8ood – hChk Vprbp WD repeat domain (mutant) + inhibitor
- 7v7c – hChk Vprbp in DDB1-VPRBP-VPR-UNG2 complex – Cryo EM
- 5aja – hChk Vprbp WD repeat domain + VPX + SAMHD1
Other Chk
- 1wak – hChk Sprk1
- 3dak – hChk Osr1 kinase domain
- 7okw – hChk Osr1 C-terminal
- 4aw2 – hChk Mrckα kinase domain
- 4pxw, 8ood – hChk Vprbp WD repeat domain (mutant)
- 7v7c – hChk Vprbp in DDB1-VPRBP-VPR-UNG2 complex – Cryo EM
- 1uf0 – hChk Dcamkl1 DCX domain – NMR
- 1u5q – rChk Tao2 kinase domain
- 2cos – mChk Lats2 – NMR
- 1xte, 1xtn, 6edx – mChk Sgk3 PX domain
- 4yom – mChk Brsk2
- 4ynz – mChk Brsk1 N terminal domain
- 5iri – mChk Brsk1 residues 592-719
- 5oat, 7mp8 – rfbChk Pink1– red flour beetle
- 7t3x – Chk Pink1 (mutant) – louse
- 4f0g – smChk Roco4 kinase domain – slime mold
- 5tos – AtChk Bik1
- 1q8z, 1zyc – yChk
- 1how, 1zxe, 1zy4 – yChk (mutant)
- 1ow5, 1x9x – yChk Ste11 SAM domain – NMR
- 2kio, 2kit, 1w1n – yChk Tor1 FATC domain – NMR
- 3gre – yChk Vps15 WD repeat domain
- 3osm, 3ost - yChk Kcc4 kinase domain
- 5yyx – yChk Mek1 FHA domain
- 6jxc, 6jxa – yChk Tel1 – Cryo EM
- 6u69 – CaChk Yck2 – Candida albicans
- 6sl1, 6sl0, 6skz, 6sky – Chk Tel1 – Chaetonium thermophilum – Cryo EM
- 6ra0 – CeChk Dkf1 – Chaenorhabditis elegans
- 7z6e – CeChk Mrck1 regulatory domain
- 6tlb – Chk – Plasmodium falciparum
Other Chk complexes
- 1wbp, 7dd1 – hChk Sprk1 + peptide
- 3beg – hChk Srpk1 + splicing factor SF2
- 3hdm, 3hdn, 7pue – hChk Sgk1 (mutant) + inhibitor
- 2r5t – hChk Sgk3 + AMPPNP
- 4yff, 4yfi, 6b5j, 7mgj, 7mgk – hChk Tnni3k + inhibitor
- 2v3s – hChk Osr1 + hChk Wnk4 peptide
- 2vwi – hChk Osr1 kinase domain + ANP
- 7que, 7quf – hChk Drak1 kinase domain + inhibitor
- 4crs – hChk N2 kinase domain + ATPγS
- 3tku, 4ual, 3qfv, 5ote, 5otf – hChk Mrckβ + inhibitor
- 4uak – hChk Mrckβ + ADP
- 5aja, 4z8l, 4cc9 – hChk Vprbp WD repeat domain + VPX + SAMHD1
- 5jk7 – hChk Vprbp WD repeat domain + VPX + DDB1 + UDG
- 3wa0, 4p7i – hChk Vprbp residues 1417-1506 + merlin
- 4wzx – hChk Ulk3 MIT 2 domain + inhibitor
- 5ci7 – hChk Ulk1 (mutant) + inhibitor
- 4wnp, 4wno – hChk Ulk1 + IST1 homolog
- 5b5w, 5b6b, 5brk – hChk Lats1 residues 622-704 + MOB1
- 5yz0 – hChk Atr + Atr-interacting protein – Cryo EM
- 6bdn – hChk Tao3 kinase domain + ADP
- 5yh3 – hChk Fam20C 141-578 + pseudokinase Fam20A
- 2gcd – rChk Tao2 kinase domain + staurosporine
- 1u5r – rChk Tao2 kinase domain + ATP
- 5yj9, 7mp9 – rfbChk Pink1 kinase domain + AMPPNP
- 6bn1 – DmChk Hippo SARAH domain + Shar-Pei
- 3hgk – Chk Pto + effector protein AVRPTOB – Currant tomato
- 3p86, 3ppz - AtChk Ctr1 + staurosporine
- 4f0f – smChk Roco4 kinase domain + APPCP
- 4f1m, 4f1o – smChk Roco4 kinase domain (mutant) + APPCP
- 4f1t, 4yzm, 4yzn – smChk Roco4 kinase domain + inhibitor
- 5fvm - Tor2 + LST8 - Kluyveromyces marxianus
- 5kc2 - yVps15 + Vps34 - Cryo EM
- 5dfz - yVps15 + Vps34 + Vps30 + VPSAP28 + VPSAP30 - Cryo EM
- 1q8y, 1q97, 1q99, 1zyd – yChk + nucleotide
- 1zy5 – yChk (mutant) + nucleotide
- 2jd5 – yChk + NPL-3P
- 4lqs, 4lqq, 4lqp – yChk Cbk1 residues 251-756 + Cbk1 activator Mob2
- 6emk – yChk Tor2 + LST8 + TSC11 + AVO1 + AVO2 – Cryo EM
- 6s8f – yChk Tel1 + AMPPNP – Cryo EM
- 5yyz – yChk Mek1 FHA domain + Hop1
- 5x6o, 6z3a, 7wzr, 7wzw– yChk Mec1 + LCD1 – Cryo EM
- 6z2w, 6z2x – yChk Mec1 (mutant) + LCD1 – Cryo EM
- 7kue – yChk Kin28 in TFIIK complex – Cryo EM
- 6u6a – CaChk Yck2 + inhibitor
- 5fvm – Chk Tor2 + LST8 – Kluyveromyces maximanus
Serine/threonine protein kinase Rad53 see Rad53
Serine/threonine protein kinase Gsk3B see Glycogen synthase kinase 3

Proteopedia Page Contributors and Editors (what is this?)

Michal Harel, Joel L. Sussman, Openfox, Jaime Prilusky

@@ Line 139: / Line 139: @@
 *'''Chk24 (Mst3)''' or STK24
 **[[3a7f]], [[3a7g]], [[3a7h]], [[3a7i]], [[3a7j]], [[3ckw]] – hChk24 kinase domain
-**[[4w8e]], [[4w8d]], [[4u8z]], [[4qmm]], [[4qmn]], [[4qmo]], [[4qmp]], [[4qmq]], [[4qms]], [[4qmt]], [[4qmu]], [[4qmv]], [[4qmw]], [[4qmx]], [[4qmy]], [[4qmz]], [[4qna]], [[4qo9]], [[4u8z]], [[7b30]], [[7b31]], [[7b32]], [[7b33]], [[7b34]], [[7b35]], [[8bzi]], [[8bzj]], [[8qlr]], [[8qls]], [[8qlt]] – hChk Mst3 + inhibitor
+**[[4qmm]], [[4qmn]], [[4qmo]], [[4qmp]], [[4qmq]], [[4qms]], [[4qmt]], [[4qmu]], [[4qmv]], [[4qmw]], [[4qmx]], [[4qmy]], [[4qmz]], [[4qna]], [[4qo9]], [[4u8z]], [[4w8d]], [[4w8e]], [[7b30]], [[7b31]], [[7b32]], [[7b33]], [[7b34]], [[7b35]], [[8bzi]], [[8bzj]], [[8qlr]], [[8qls]], [[8qlt]] – hChk Mst3 + inhibitor
 **[[8qlq]] – hChk Mst3 + macrocyclic inhibitor
 **[[3ckx]] – hChk24 kinase domain + staurosporin
@@ Line 152: / Line 152: @@
 *'''Chk26 (Mst4)'''
 **[[3ggf]], [[7b36]] – hChk Mst4 + inhibitor
-**[[4geh]], [[3w8i]] - hChk Mst4 dimerization domain + programmed cell death protein 10
+**[[[3w8i]], [4geh]] - hChk Mst4 dimerization domain + programmed cell death protein 10
 **[[4fza]], [[4fzd]], [[4fzf]] – hChk Mst4 (mutant) + calcium-binding protein
 *'''Chk32'''
@@ Line 175: / Line 175: @@
 **[[2uzr]], [[2uzs]], [[7myx]] – hRac-α hChk pleckstrin homology domain (mutant)
 **[[1h10]], [[1unq]], [[2uvm]] – hRac-α hChk pleckstrin homology domain + inositol tetrakisphosphate
-**[[3o96]], [[4ejn]], [[6s9w]], [[6s9x]], [[6hhj]], [[6hhi]], [[6hhh]], [[6hhg]], [[6hhf]] - hRac-α hChk + inhibitor
+**[[3o96]], [[4ejn]], [[6hhf]], [[6hhg]], [[6hhh]], [[6hhi]], [[6hhj]], [[6s9w]], [[6s9x]] - hRac-α hChk + inhibitor
 **[[5kcv]], [[7nh4]], [[7nh5]] - hRac-α hChk (mutant) + inhibitor
-**[[4gv1]], [[4ekl]] - hRac-α hChk kinase domain + inhibitor
+**[[4ekl]], [[4gv1]] - hRac-α hChk kinase domain + inhibitor
 **[[3qkm]], [[6ccy]] - hRac-α hChk kinase domain (mutant) + inhibitor
 **[[6buu]] - hRac-α hChk kinase domain + bisubstrate peptide
@@ Line 202: / Line 202: @@
 **[[1uwh]], [[3c4c]], [[6v2u]], [[6xfp]], [[6xlo]], [[8f7o]], [[8f7p]]  – hB-Raf kinase domain + anticancer drug
 **[[1uwj]], [[6p3d]] – hB-Raf kinase domain (mutant) + anticancer drug
-**[[2fb8]], [[3d4q]], [[3ii5]], [[3psd]], [[3skc]], [[3tv6]], [[4g9c]], [[4ksp]], [[4ksq]], [[3psb]], [[3ppj]], [[3ppk]], [[3prf]], [[3pri]], [[3tv4]], [[4dbn]], [[4e4x]], [[4mbj]], [[4ehe]], [[3q4c]], [[3q96]], [[3e26]], [[4h58]], [[4e26]], [[4fc0]], [[4pp7]], [[6cad]], [[7shv]] – hB-Raf kinase domain + pyrazole inhibitor
+**[[2fb8]], [[3d4q]], [[3e26]], [[3ii5]], [[3ppj]], [[3ppk]], [[3prf]], [[3pri]], [[3psb]], [[3psd]], [[3q4c]], [[3q96]], [[3skc]], [[3tv4]], [[3tv6]], [[4dbn]], [[4e26]], [[4e4x]], [[4ehe]], [[4fc0]], [[4g9c]], [[4h58]], [[4ksp]], [[4ksq]], [[4mbj]], [[4pp7]], [[6cad]], [[7shv]] – hB-Raf kinase domain + pyrazole inhibitor<br />
-**[[4jvg]], [[4ehg]], [[4fk3]], [[3idp]], [[4g9r]], [[4wo5]], [[4mnf]], [[4r5y]], [[4rzv]], [[4rzw]], [[4xv1]], [[4xv2]], [[4xv3]], [[4xv9]], [[4yht]], [[5c9c]], [[5hi2]], [[5ita]], [[5jrq]], [[5jsm]], [[5jt2]], [[6nsq]], [[6p7d]], [[6uuo]] – hB-Raf kinase domain (mutant) + pyrazole inhibitor
+**[[3idp]], [[4ehg]], [[4fk3]], [[4g9r]], [[4jvg]], [[4mnf]], [[4r5y]], [[4rzv]], [[4rzw]], [[4wo5]], [[4xv1]], [[4xv2]], [[4xv3]], [[4xv9]], [[4yht]], [[5c9c]], [[5hi2]], [[5ita]], [[5jrq]], [[5jsm]], [[5jt2]], [[6nsq]], [[6p7d]], [[6uuo]] – hB-Raf kinase domain (mutant) + pyrazole inhibitor
-**[[5csw]], [[5csx]], [[5ct7]], [[5fd2]], [[5hid]], [[5hie]], [[5val]], [[5vam]], [[6b8u]], [[6n0q]], [[6n0p]], [[7k0v]], [[7p3b]], [[7p3v]], [[8c7x]], [[8c7y]] - hB-Raf kinase domain + inhibitor
+**[[5csw]], [[5csx]], [[5ct7]], [[5fd2]], [[5hid]], [[5hie]], [[5val]], [[5vam]], [[6b8u]], [[6n0p]], [[6n0q]], [[7k0v]], [[7p3b]], [[7p3v]], [[8c7x]], [[8c7y]] - hB-Raf kinase domain + inhibitor
 **[[6v34]] – hB-Raf kinase domain (mutant) + inhibitor
 **[[4mne]] – hB-Raf kinase domain + MAPKK1
@@ Line 225: / Line 225: @@
 **[[5j18]] – hB-Raf RAS-binding domain + inhibitor - NMR
 **[[6pts]], [[6ptw]] – hB-Raf 56-187 + Kras + apolipoprotein + GMPPNP - NMR
-**[[6uan]], [[6q0k]] – hB-Raf + 14-3-3 ζ – Cryo EM
+**[[6q0k]], [[6uan]] – hB-Raf + 14-3-3 ζ – Cryo EM
 **[[6nyb]] – hB-Raf + 14-3-3 ζ + MEK1 – Cryo EM
 **[[6q0t]], [[6q0j]] – hB-Raf (mutant) + 14-3-3 ζ + MEK1 – Cryo EM

Serine/threonine protein kinase 3D structures: Difference between revisions

Revision as of 07:44, 19 August 2026

3D structures of serine/threonine protein kinase

Proteopedia Page Contributors and Editors (what is this?)

Navigation menu

Page actions

Page actions

Personal tools

Navigation

Search

Tools